Andrew J. Garton

2.3k total citations
24 papers, 1.9k citations indexed

About

Andrew J. Garton is a scholar working on Molecular Biology, Biochemistry and Oncology. According to data from OpenAlex, Andrew J. Garton has authored 24 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Biochemistry and 5 papers in Oncology. Recurrent topics in Andrew J. Garton's work include Protein Tyrosine Phosphatases (7 papers), Lipid metabolism and biosynthesis (7 papers) and Muscle metabolism and nutrition (3 papers). Andrew J. Garton is often cited by papers focused on Protein Tyrosine Phosphatases (7 papers), Lipid metabolism and biosynthesis (7 papers) and Muscle metabolism and nutrition (3 papers). Andrew J. Garton collaborates with scholars based in United States, United Kingdom and Australia. Andrew J. Garton's co-authors include Nicholas K. Tonks, Stephen J. Yeaman, Andrew Flint, David G. Campbell, Roger Colbran, David Carling, D. Grahame Hardie, John D. Haley, Sarajane Ross and Mark X. Sliwkowski and has published in prestigious journals such as Journal of Biological Chemistry, The EMBO Journal and Blood.

In The Last Decade

Andrew J. Garton

24 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew J. Garton United States 18 1.2k 404 345 333 302 24 1.9k
Jin-Keon Pai United States 19 1.5k 1.2× 385 1.0× 177 0.5× 353 1.1× 250 0.8× 31 2.1k
Xiliang Zha China 26 1.1k 0.9× 273 0.7× 242 0.7× 123 0.4× 258 0.9× 78 1.8k
Sandy Giuliano France 23 1.4k 1.2× 656 1.6× 335 1.0× 178 0.5× 280 0.9× 29 2.1k
Roch‐Philippe Charles Switzerland 22 1.0k 0.9× 447 1.1× 240 0.7× 93 0.3× 137 0.5× 35 1.9k
F. Gregory Buchanan United States 17 877 0.7× 366 0.9× 137 0.4× 109 0.3× 169 0.6× 19 1.8k
Trevor R. Walker United Kingdom 16 739 0.6× 200 0.5× 409 1.2× 241 0.7× 126 0.4× 22 1.4k
Valeria Bertagnolo Italy 25 1.5k 1.3× 345 0.9× 202 0.6× 159 0.5× 356 1.2× 85 2.0k
Sizhen Gao United States 9 1.4k 1.1× 372 0.9× 198 0.6× 164 0.5× 403 1.3× 9 2.1k
Keyvan Mahboubi United States 15 700 0.6× 284 0.7× 331 1.0× 166 0.5× 60 0.2× 22 1.3k
Shuangxing Yu United States 27 2.7k 2.2× 436 1.1× 311 0.9× 182 0.5× 639 2.1× 33 3.2k

Countries citing papers authored by Andrew J. Garton

Since Specialization
Citations

This map shows the geographic impact of Andrew J. Garton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew J. Garton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew J. Garton more than expected).

Fields of papers citing papers by Andrew J. Garton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew J. Garton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew J. Garton. The network helps show where Andrew J. Garton may publish in the future.

Co-authorship network of co-authors of Andrew J. Garton

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew J. Garton. A scholar is included among the top collaborators of Andrew J. Garton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew J. Garton. Andrew J. Garton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Garton, Andrew J., Scott B. Seibel, Lori Lopresti‐Morrow, et al.. (2017). Anti-KIT Monoclonal Antibody Treatment Enhances the Antitumor Activity of Immune Checkpoint Inhibitors by Reversing Tumor-Induced Immunosuppression. Molecular Cancer Therapeutics. 16(4). 671–680. 27 indexed citations
2.
London, Cheryl A., Heather L. Gardner, Gerald Post, et al.. (2016). KTN0158, a Humanized Anti-KIT Monoclonal Antibody, Demonstrates Biologic Activity against both Normal and Malignant Canine Mast Cells. Clinical Cancer Research. 23(10). 2565–2574. 29 indexed citations
3.
LaVallee, Theresa, Diego Alvarado, Andrew J. Garton, et al.. (2015). Emerging Receptor Tyrosine Kinase Drug Targets: Implications for Antibody-Based Therapies for Oncology and Immunologic Disorders. Critical Reviews™ in Oncogenesis. 20(5-6). 485–508. 4 indexed citations
4.
Vigil, Dominico, Tai Young Kim, Andrew J. Garton, et al.. (2012). ROCK1 and ROCK2 Are Required for Non-Small Cell Lung Cancer Anchorage-Independent Growth and Invasion. Cancer Research. 72(20). 5338–5347. 109 indexed citations
5.
Garton, Andrew J., et al.. (2008). Quantitative High‐Throughput Cell‐Based Assays for Inhibitors of ROCK Kinases. Methods in enzymology on CD-ROM/Methods in enzymology. 439. 491–500. 10 indexed citations
6.
Garton, Andrew J. & Nicholas K. Tonks. (1999). Regulation of Fibroblast Motility by the Protein Tyrosine Phosphatase PTP-PEST. Journal of Biological Chemistry. 274(6). 3811–3818. 116 indexed citations
7.
Garton, Andrew J.. (1997). Comparison of dose doubling with probenecid for sustaining serum cefuroxime levels. Journal of Antimicrobial Chemotherapy. 40(6). 903–906. 14 indexed citations
8.
Garton, Andrew J., Mary Rose Burnham, Amy H. Bouton, & Nicholas K. Tonks. (1997). Association of PTP-PEST with the SH3 domain of p130cas; a novel mechanism of protein tyrosine phosphatase substrate recognition. Oncogene. 15(8). 877–885. 133 indexed citations
9.
MacKintosh, Carol, Andrew J. Garton, D. Barford, et al.. (1996). Further evidence that inhibitor‐2 acts like a chaperone to fold PP1 into its native conformation. FEBS Letters. 397(2-3). 235–238. 52 indexed citations
10.
Garton, Andrew J., Andrew Flint, & Nicholas K. Tonks. (1996). Identification of p130 cas as a Substrate for the Cytosolic Protein Tyrosine Phosphatase PTP-PEST. Molecular and Cellular Biology. 16(11). 6408–6418. 233 indexed citations
11.
Garton, Andrew J., et al.. (1996). Evidence for a multi‐domain structure for hormone‐sensitive lipase. FEBS Letters. 396(1). 90–94. 27 indexed citations
12.
Garton, Andrew J. & Nicholas K. Tonks. (1994). PTP-PEST: a protein tyrosine phosphatase regulated by serine phosphorylation.. The EMBO Journal. 13(16). 3763–3771. 107 indexed citations
13.
Garton, Andrew J., et al.. (1993). Domain structure of hormone-sensitive lipase. Biochemical Society Transactions. 21(3). 233S–233S. 2 indexed citations
14.
Gray, Michael A., J. R. Greenwell, Andrew J. Garton, & Barry E. Argent. (1990). Regulation of maxi-K+ channels on pancreatic duct cells by cyclic AMP-dependent phosphorylation. The Journal of Membrane Biology. 115(3). 203–215. 62 indexed citations
15.
Garton, Andrew J. & Stephen J. Yeaman. (1990). Identification and role of the basal phosphorylation site on hormone‐sensitive lipase. European Journal of Biochemistry. 191(1). 245–250. 110 indexed citations
16.
Garton, Andrew J., David G. Campbell, David Carling, et al.. (1989). Phosphorylation of bovine hormone‐sensitive lipase by the AMP‐activated protein kinase. European Journal of Biochemistry. 179(1). 249–254. 236 indexed citations
17.
Garton, Andrew J., David G. Campbell, Philip Cohen, & Stephen J. Yeaman. (1988). Primary structure of the site on bovine hormone‐sensitive lipase phosphorylated by cyclic AMP‐dependent protein kinase. FEBS Letters. 229(1). 68–72. 89 indexed citations
18.
Lee, Fook-Thean, John B. Adams, Andrew J. Garton, & Stephen J. Yeaman. (1988). Hormone-sensitive lipase is involved in the hydrolysis of lipoidal derivatives of estrogens and other steroid hormones. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 963(2). 258–264. 50 indexed citations
19.
Oldham, Harriet G., et al.. (1986). Drug metabolism kinetic studies in a hepatocyte model. Food and Chemical Toxicology. 24(6-7). 761–762. 4 indexed citations
20.
Colbran, Roger, Andrew J. Garton, Susan R. Cordle, & Stephen J. Yeaman. (1986). Regulation of cholesterol ester hydrolase by cyclic AMP‐dependent protein kinase. FEBS Letters. 201(2). 257–261. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jin-Keon Pai Breakdown of academic impact, for papers by Xiliang Zha Breakdown of academic impact, for papers by Sandy Giuliano Breakdown of academic impact, for papers by Roch‐Philippe Charles Breakdown of academic impact, for papers by F. Gregory Buchanan Breakdown of academic impact, for papers by Trevor R. Walker Breakdown of academic impact, for papers by Valeria Bertagnolo Breakdown of academic impact, for papers by Sizhen Gao Breakdown of academic impact, for papers by Keyvan Mahboubi Breakdown of academic impact, for papers by Shuangxing Yu
Rankless by CCL
2026